- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05963191
CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome (CADLYNCH)
Evaluation of the CAD-EYE System for the Detection of Colorectal Neoplastic Lesions in Patients With Lynch Syndrome
Lynch syndrome (LS) is the most common genetic predisposition syndrome for colorectal cancer (CRC), responsible for around 2-4% of cancers. It is characterized by a pathogenic germline mutation in one of the DNA mismatch repair genes (path_MMR) MLH1, MSH2, MSH6, PMS2 or a deletion in the 3' region of the Epcam gene. Patients followed up for LS are at high risk of developing CRC at an early age, and have a high cumulative CRC risk. In this context, CRC screening by colonoscopy is of major importance, as it is associated with a reduction in both CRC incidence and mortality.
In France, the Institut National du Cancer (INCa) recommends colonoscopy with indigo carmine chromoendoscopy (CE), as it is associated with a significant increase in the adenoma detection rate (ADR) compared with white light. However, EC is not routinely performed in clinical practice, as it is a time-consuming technique requiring a dedicated slot with a trained operator.
Recent years have seen the emergence of artificial intelligence techniques for real-time polyp detection aids or CADe devices. These easy-to-use systems have shown very promising results compared with high-definition (HD) white light. Indeed, data from the first meta-analysis of 5 randomized controlled trials (4354 patients) confirmed a significantly higher ADD in the CADe group than in the HD group (36.6% vs. 25.2%; 95% CI], 1.27-1.62; P < 0.01; I2 Z 42%) 10. The CAD EYE system (Fujifilm) is a CADe device supporting both detection (sensitivity > 95%) and characterization of colonic polyps in real time.
To date, artificial intelligence has never been evaluated for CRC screening in patients followed up for LS. The aim of this work is to evaluate the effectiveness of the CAD EYE system in this specific population. To this end, we intend to conduct a randomized, controlled, non-inferiority trial comparing CAD EYE with CE in patients with LS.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Guillaume Perrod, MD
- Phone Number: +33 1 56 09 34 17
- Email: guillaume.perrod@aphp.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Confirmed pathogenic mutation (path_MLH1, path_MSH2, path_MSH6, path_PMS2, path_EpCAM)
- Male or female of legal age at time of colonoscopy prescription.
- Patient agreeing to participate in the study
- Person affiliated with or benefiting from a social security scheme
- Free, informed and express consent
Exclusion Criteria:
- Patient undergoing total colectomy with ileoanal or ileosigmoid anastomosis
- Patient with a history of Crohn's disease or ulcerative colitis
- Patients with a known allergy or intolerance to polyethylene glycol and ascorbic acid.
- Patients unable to undergo fractionated colonic preparation
- Inadequate colonic preparation: Boston sub-score <2 per segment
- Patient under guardianship or protected person
- Patient who does not understand French or cannot read
- Person not affiliated to a Social Security system.
- Pregnant women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CAD-EYE group: Colorectal cancer screening with CAD EYE colonoscopy
The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination.
In the CAD EYE group, descent is performed under white light, with the CAD EYE system switched on (device with CE mark).
When polyps are detected, they are rigorously described and histological predictions of endoscopist and CAD EYE will be reported separately.
|
The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination. A colonoscopy is considered complete if the endoscope reaches the appendicular orifice or the terminal ileum. In line with recommendations, water lavage (using a lavage pump) and aspiration of food residues will be performed on ascent and/or descent to visualize the entire colonic mucosa. In the CAD EYE group, descent is performed under white light, with the CAD EYE system switched on. When polyps are detected, they are rigorously described and histological predictions of endoscopist and CAD EYE will be reported separately. Then polyps will be removed by polypectomy or mucosectomy. Removed polyps are then sent for anatomopathological analysis. |
No Intervention: CE group : Colorectal cancer screening with indigo carmine chromo colonoscopy
The colonoscopy procedure for each patient will be no different from a conventional colonoscopy examination.
In the CE group, descent is performed under white light with indigo carmin chromoendoscopy (0.4%) applied through a catheter spray.
When polyps are detected, they are rigorously described and histological prediction of the endoscopist reported.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
to evaluate the effectiveness of the CAD EYE system in screening for neoplastic lesions in Lynch syndrome.
Time Frame: Through study completion, an average of 2 years
|
Comparison of the adenoma detection rate (ADR) between the CAD-EYE group and the indigo carmin chromoendoscopy (CE) group (reference technique).
|
Through study completion, an average of 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Detection rates of specific lesions
Time Frame: Through study completion, an average of 2 years
|
Mean number of adenomas and serrated lesions per patient
|
Through study completion, an average of 2 years
|
Diagnostic performance of CAD EYE
Time Frame: Through study completion, an average of 2 years
|
Comparison of the diagnostic performance of CAD EYE assessed by specificity, negative predictive value and positive predictive value for the characterization (adenoma/hyperplastic) of colonic polyps with the CAD EYE automated detection system.
The anatomopathology of polyps was taken as the diagnostic reference.
|
Through study completion, an average of 2 years
|
Rate of resect and discard strategy
Time Frame: Through study completion, an average of 2 years
|
Evaluation of the feasibility of a "resect and discard" strategy in Lynch Syndrome.
Retrospective analysis comparing CAD-EYE histological prediction vs. endoscopist prediction, using histological report as reference examination (Sensitivity and negative predictive value).
|
Through study completion, an average of 2 years
|
Time of Colonoscopies
Time Frame: Through study completion, an average of 2 years
|
Comparison of different procedure times between the 2 groups.
Total procedure time will be defined as the time from endoscope insertion to extraction through the anus.
Withdrawal time will be defined as the time spent on inspection, from the cecum to extraction of the endoscope through the anus, excluding the time required for polypectomy.
|
Through study completion, an average of 2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Metabolic Diseases
- Neoplasms
- Neoplasms by Site
- Disease
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Genetic Diseases, Inborn
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Colorectal Neoplasms
- Neoplastic Syndromes, Hereditary
- DNA Repair-Deficiency Disorders
- Syndrome
- Colorectal Neoplasms, Hereditary Nonpolyposis
Other Study ID Numbers
- SFED 156
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lynch Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHigh-Frequency Microsatellite Instability | Mismatch Repair Gene Mutation | Mutation-Negative Lynch Syndrome | Mutation-Positive Lynch SyndromeUnited States
-
San Raffaele UniversityUnita' di Gastroenterologia - Policlinico Universitario di Bari; Unita' di... and other collaboratorsRecruitingLynch Syndrome | MLH1 Gene Mutation | MSH2 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | Lynch Syndrome II | Small Bowel Adenocarcinoma | Lynch Syndrome IItaly
-
Tel-Aviv Sourasky Medical CenterRambam Health Care Campus; Rabin Medical Center; Sheba Medical Center; Soroka University...Not yet recruitingLynch Syndrome I (Site-specific Colonic Cancer)Israel
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...Not yet recruitingLynch Syndrome | ContraceptionItaly
-
National Cancer Institute (NCI)RecruitingLynch SyndromeUnited States, Puerto Rico
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Imperial College LondonEnrolling by invitation
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Hospital Clinic of BarcelonaFundacion Clinic per a la Recerca BiomédicaCompleted
-
UNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina, Chapel Hill; National Center for Advancing Translational... and other collaboratorsRecruitingLynch SyndromeUnited States
Clinical Trials on Colorectal cancer screening with CAD EYE colonoscopy
-
East Bay Institute for Research and EducationCompletedColorectal CancerUnited States
-
Smart Medical Systems Ltd.FujifilmRecruitingColorectal Cancer | AdenomaGermany
-
Instituto Ecuatoriano de Enfermedades DigestivasRecruitingColorectal Neoplasms | Colorectal DysplasiaEcuador
-
Sir Run Run Shaw HospitalNot yet recruitingColorectal Cancer | Adenoma | Adenomatous Polyps | Advanced AdenomaChina
-
Dr. Horst Schmidt Klinik GmbHRecruiting
-
University of California, DavisCalifornia Academy of Family PhysiciansCompletedColorectal NeoplasmsUnited States
-
Corporacion Parc TauliEnrolling by invitation
-
University of WashingtonNational Cancer Institute (NCI)Completed
-
Maria Sklodowska-Curie National Research Institute...Centre of Postgraduate Medical Education; Ministry of Health, PolandUnknown
-
Johannes Gutenberg University MainzUnknownFocus of the Study is to Evaluate a New Developed Deep-learning Computer-aided Detection System in Combination With LCI for Colorectal Polyp DetectionGermany